Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) dropped 10.7% on Thursday . The stock traded as low as $11.25 and last traded at $11.25. Approximately 1,352 shares were traded during trading, a decline of 76% from the average daily volume of 5,599 shares. The stock had previously closed at $12.60.
Nihon Kohden Stock Down 10.8%
The stock has a market capitalization of $1.91 billion, a P/E ratio of 19.96 and a beta of 0.35. The company has a fifty day simple moving average of $12.23 and a two-hundred day simple moving average of $13.21.
Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported $0.18 earnings per share (EPS) for the quarter. Nihon Kohden had a return on equity of 7.20% and a net margin of 6.23%. The business had revenue of $439.11 million during the quarter.
About Nihon Kohden
(
Get Free Report)
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.
Featured Articles
Before you consider Nihon Kohden, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.
While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access